Simvastatin After Aneurysmal Subarachnoid Hemorrhage

Completed

Phase N/A Results

Summary of Purpose

To determine whether simvastatin reduces serum markers of brain injury and lessens vasospasm after SAH.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 August 2005.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • NIH research grant R21NS4487-01 & Merck and Co, Inc. D.T.L

Trial Design

Randomized, double-blind, placebo-controlled trial.

Contacts

Not available